List your practice on InjuredCare | Log in / Sign up

3M Combat Arms Earplugs – Hearing Loss

3M Combat Arms Earplugs – Hearing Loss

The Combat Arms Earplug, Version 2, manufactured by 3M, was sold to the U.S. military between 2003 and 2015. The earplugs are designed as "dual-ended," allowing the user to insert them in either direction. The product was sold to all branches of the armed forces of the United States, specifically represented to protect the wearer from hearing loss caused by gunfire, bombings, explosions, and air traffic.

Studies have now shown that the earplugs were defective, leading to hearing loss by many who used them. Research shows that the ear-buds were too short, making it difficult or impossible for users to fully insert them into their ears. As a result, the earplugs tended to loosen or relocate in the ear, causing a break in the seal and allowing dangerous levels of sound through. Users have been diagnosed will all levels of hearing loss, from tinnitus (a ringing in the ear) to total hearing loss.

The earplugs, originally developed and marketed by Aero Technologies, have been sold by 3M since 2008. In 2018, after a company whistleblower came forward and alleged that 3M knew the earplugs were not up to standards, 3M agree to pay more than $9 million to settle a False Claims Act prosecution by federal authorities. In the lawsuit, the government contended that both 3M and Aero Technologies knew of the defects but failed to disclose them.

3M stopped manufacturing the product in 2015 but has never issued a recall of the earplugs.

A number of civil lawsuits also have been filed by individuals who suffered hearing loss when using the Combat Arms earplugs.

Related Articles

  • OxyContin

    OxyContin

    The Brand Name for Oxycodone OxyContin, the trade name for the opioid oxycodone, was first developed in a laboratory more than 100 years ago (1916) at the University of Frankfurt, Read More...

  • Amiodarone

    Amiodarone

    The first version of amiodarone approved by the FDA (1985) was Pacerone, sold by Upsher-Smith Labs. Another common amiodarone product is marketed by Wyeth-Ayerst Labs under the nam Read More...

  • Ambien

    Ambien

    Ambien is manufactured by Sanofi Aventis and was approved by the FDA for the treatment of insomnia in December 1992. From 2006 to 2011, around 38 million people were prescribed a z Read More...

© 2015-2022 LawConnect, Inc. All rights reserved.

CONCEPT, DESIGN and HOSTING BY GETLEGAL.COM’S WEB SERVICES TEAM..